Indomethacin embryofetopathy

Get in touch with RARE Concierge.

Contact RARE Concierge

Indomethacin embryofetopathy

Synonyms: Fetal indomethacin syndrome

Indomethacin embryofetopathy refers to the manifestations that may be observed in a fetus or newborn when the mother has taken indomethacin a potent prostaglandin inhibitor and tocolytic agent that can cross placenta during pregnancy. Reported adverse fetal/neonatal effects include decreased renal function resulting in oligohydramnios closure of the ductus arteriosus and delayed cardiovascular adaptation at birth. These effects are usually transient and reversible. Indomethacin may also be a risk factor for cerebral injury (periventricular leukomalacia) and necrotizing enterocolitisin preterm infants.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http: // Data version October 2023.

Newly diagnosed with
Indomethacin embryofetopathy?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Clinical Trials

For a list of clinical trials in this disease area, please click here.